There are more reasons to stay invested, and even more reasons to start an investment in $AVXL than ever before, "even if the outcome is most likely a next P3 Precision Medicine trial based on clearly understood responder characteristics."
BTW, I'm enjoying the highlighting of uncertainty (incomplete trial read out) to foment doubt and incite fear as it keeps it interesting and motivates trading activity.